TrialIntensive care medicine2009

Comprehensive safety analysis of concomitant drotrecogin alfa (activated) and prophylactic heparin use in patients with severe sepsis.

Mitchell Levy et al.PubMed ↗Publisher ↗

No numbers read from the abstract.